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ABSTRACT

International Journal of Exercise Science 6(2) : 91-97, 2013. L-Arginine AlphaKetoglutarate (AAKG) is purported to stimulate the release of nitric oxide, and is suggested to
facilitate muscular performance by increasing blood flow and increase oxygen and nutrient
delivery to the working muscle. However, the ergogenic benefit of AAKG during resistance
exercise has not been established. Therefore the purpose of this study was to investigate the
effects of acute AAKG ingestion in active ROTC Cadets on measures of one-repetition maximal
strength (1RM) and muscular endurance. Nineteen apparently healthy males ingested either
AAKG (3 g) or a placebo 45 minutes prior to resistance testing in a randomized, double-blind
crossover design. Initially, blood lactate (BLA) was obtained followed by 1RM testing on the
barbell bench press and leg press. Upon determination of 1RM, participants completed
repetitions to failure at 60% of 1RM. Blood lactate measures were immediately taken following
the final repetition. Analysis revealed no significant differences between the conditions for bench
press 1RM. Additionally, there were no differences between conditions for 1RM leg press, or for
number of repetitions performed for the bench press or leg press. Blood lactate values did
increase significantly from baseline to post-bench press in both the AAKG (t33 = 7.56, p < 0.01)
and placebo conditions (t33 = 8.45, p < 0.01). Further, BLA lactate levels were also significantly
greater post leg-press in the AAKG (t33 = 9.23, p < 0.01) and placebo (t33 = 8.10, p < 0.01). The
results indicate that acute AAKG supplementation provides no ergogenic benefit in this study.
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INTRODUCTION
Over the past decade dietary supplements
containing L-arginine have become very
popular among resistance-trained athletes.
This semi-essential amino acid is intended
to increase strength, power, and recovery
from intense muscular exercise (1). Larginine is used by all cells and plays a role
in numerous physiological functions such

as protein synthesis, synthesis of other
amino acids, detoxification of ammonia,
and may readily be converted αketoglutarate (AKG) for ATP production (1,
3). However, the purported ergogenic
benefits of L-arginine probably stem from
its (1) role in the synthesis of creatine; (2)
contribution in the release of growth
hormone and/or (3) function as a precursor
in the biosynthesis of nitric oxide (NO) (4).
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acute effects of L-arginine α-ketoglutarate
(AAKG) supplementation on muscular
endurance and blood pressure responses.
Twelve
resistance-trained
participants
consumed 3,700 mg of either AAKG or
placebo (maltodextrin) at two intervals (4
hr and 30 min) prior to completion of chinups, reverse chin-ups and push-ups to
exhaustion. Blood pressure (BP) responses
were monitored throughout each trial
session. Results revealed that AAKG
provided no ergogenic benefit during the
muscular endurance tests and no
differences were observed in BP across
trials.

It is the latter that has gotten much of the
attention as supplements containing Larginine are often advertised as “nitric
oxide stimulators” (NO stimulators). There
is a supportive rationale for such claims as
NO can be produced from L-arginine via
the enzyme NO synthase (1). NO produces
a potent vasodilatory effect on blood
vessels thereby possibly improving muscle
blood flow during resistance training, thus
allowing a greater delivery of fuel
substrates and removal of lactate and
ammonia (4). Conversely, there is still no
clear evidence to conclude L-arginine’s role
as a NO stimulator that augments
resistance exercise performance in healthy
individuals (1).

To the authors knowledge, no investigation
has explored the acute ingestion of AAKG
during a bout of weight training; therefore,
the purpose of this study was to investigate
the acute ergogenic potential of AAKG on
one-repetition maximum (1RM) strength
and muscular endurance, as well as its’
impact on blood lactate (BLA) values in
active ROTC Cadets.

Only a few studies have investigated the
effects of L-arginine on resistance training
performance.
Chronic
L-arginine
supplementation has produced mixed
results with some studies observing
benefits in anaerobic power (3), muscular
strength (3, 5, 14), and muscular endurance
(15) while others have found no effect on
these same performance variables (7, 8).
Stevens et al. (14) used 13 participants to
assess the acute responses of L-arginine
ingestion. L-arginine or a placebo (sucrose)
was isocalorically administered at 45, 30
and 10 min before exercise using an
isokinetic dynamometer. When compared
with placebo, total work and peak torque
were significantly greater while fatigue
index was increased after consuming Larginine. Additionally, Villaverde et al. (15)
reported observing decreased muscular
fatigue
evaluated
by
isokinetic
dynamometer following 15 days of oral Larginine supplementation (3g/day). In
contrast, Greer and Jones (8) used a double
blind, cross-over design to investigate the
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METHODS
Participants
Nineteen apparently healthy, male ROTC
Cadets volunteered for this investigation.
Participants reported being free of any
medical conditions, which would hinder
their ability to perform the exercise
protocol. Additionally, the cadets selfreported not using any anabolic or
metabolic supplements within the previous
month. All participants gave their informed
consent and completed a health history
questionnaire before participating in the
study. All experimental procedures were
approved by Institutional Review Board at
Mississippi State University. Demographic
data are described in Table 1.
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same nutritional intake preceding each
session. Participants were also asked to
abstain from taking any supplements,
caffeine, or energy drinks during the
investigation, as well as to refrain from
alcohol intake, and medication during the
48 h period preceding testing.

Table 1. Subject demographic information. All data
presented as mean ± standard deviation (SD).

N = 19
Age

Mean ± SD
19.42 ± 1.26

Height (cm)

176.06 ± 7.08

Weight (kg)

79.24 ± 10.57

Body Fat %

15.17 ± 4.85

Supplementation
Schedule:
AAKG
(Healthwatchers DE Inc., Bohemia, NY) or a
placebo consisting of microcrystalline
cellulose (Apotheca Inc., Woodbine, IA)
was provided to participants to be ingested
45 min pre-exercise with 300 ml of water.
The placebo was similar in color, size, and
texture to the supplement. The selected
dose for this investigation was based on a
review of prior research in this area (16)
and amounts recommended by many
currently available AAKG supplements.
One week later, participants reported to the
laboratory to complete the last session.

Protocol
Experimental Approach to the Problem:
Participants reported to the Exercise
Physiology Laboratory at the same time of
day for each of the three testing sessions.
Each session was separated by 7 days. The
first session was used to collect the
participants’ anthropometric data and serve
as a familiarization session for the testing
protocol. Participants were then randomly
assigned a treatment session of either
AAKG or placebo.
Treatments were
administered in a counterbalanced, doubleblind manner, as neither investigators nor
participants were aware of treatment order.
The research protocol is outlined in Figure
1.

Blood Collection: A single-use lancet
device was used to puncture the skin just
off the center of the finger pad. The first
flow of blood was wiped away, and then
approximately 5µL (2mm) of blood was
loaded on the lactate strip and immediately
analyzed using the Lactate Pro Analyzer
(LT 1710, ARKRAY Inc., Japan). Blood
samples were obtained pre-exercise and
immediately following both the upper and
lower body muscular endurance tests.

Figure 1. Progression of the experimental protocol
across time.

Session 1: The preliminary session was
conducted one week prior to the initiation
of the two experimental sessions. This
initial session included a verbal explanation
of the protocol, supplement restrictions
(creatine, energy drinks, caffeine, etc.), and
nutritional intake (24 h recall). During this
preliminary session participants were also
measured for height, body mass, and body

Monitoring of Exercise and Dietary Status:
Resistance trained participants were
instructed to refrain from resistance
training 48 h preceding testing and all
participants were asked to avoid any
strenuous activity 24 h prior to testing.
Also, a 24 h dietary and exercise recall was
completed
before
each
trial,
and
participants were encouraged to follow the
International Journal of Exercise Science
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composition. Height was measured to the
nearest 0.01 cm and body mass was
measured in kilograms on a physicians’
balance beam scale (Healthometer 402EXP).
Body composition was determined using
the 3 site (abdomen, thigh, and chest)
skinfold model described by Pollock and
Wilmore (11).

minutes, and then performed as many
bench press repetitions as possible until
failure occurred. Failure for the bench press
in this study was defined as the inability to
complete a repetition without assistance.
Measurement of BLA was taken within 5 s
of muscular failure.
After a 5 min recovery period, participants
began a warm-up on a Cybex 45° plate
loaded leg press (Cybex Inc., Medway, MA)
at a load of 82 kg for 12-15 repetitions,
following the identical warm-up protocol
used during the bench press. Once again,
immediately following 1RM determination,
60% of the 1RM was placed on the leg
press, and participants were again allowed
to recover for five minutes. The participants
then performed as many leg press
repetitions as possible until muscular
failure occurred. Once again, BLA
measurements were obtained within 5 s of
termination of the leg press.

Session 2 and 3: Participants reported to
the laboratory at their prescheduled time
and prepared for testing. Upon arrival,
participants were questioned about their
compliance in regards to their activity level
and completed their 24 h dietary recall for
review by a trained evaluator. If a
participant failed to meet the pretesting
guidelines required for participation in that
day’s protocol the session was rescheduled.
All participants completed their scheduled
sessions.
Following the evaluator’s review and
approval of the compliance guidelines,
participants’ ingested either the AAKG
supplement or placebo and then rested
quietly for 40 min. At the conclusion of rest
period, a measurement of BLA was
collected prior to warm-up. Participants
then warmed up on an upright stationary
bike at a pace of 60 – 70 RPM for 5 min.
Next, participants performed a 2-3 warmup sets of 10-12 repetitions using a load of
61 kg on a standard barbell bench press
(Magnum D78, Milwaukee, Wisconsin).
Three minutes of rest time was allotted
between each set. One-repetition maximum
was determined according to the methods
of Earle and Baechle (2). Each participant’s
1RM was determined in 3-5 sets.

Statistical Analysis
Data analyses were performed using SPSS
(v 18.0). Paired t-tests were performed to
assess differences in performance measures
(1RM, repetitions performed, total load)
between conditions. Finally, BLA levels
were examined utilizing repeated measures
ANOVA to examine the differences in
lactate changes from baseline to postmuscular endurance assessment between
conditions. Significant interactions were
further
analyzed
utilizing
one-way
ANOVA and paired t-tests with Bonferroni
corrections with the α-level set at p ≤ 0.05.
RESULTS

Immediately following 1RM, 60% of the
1RM was placed on the bar, and
participants were allowed to rest for 5
International Journal of Exercise Science

All 19 ROTC Cadets who initially
volunteered
completed
the
testing
procedures. There was no order effects
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observed between the 2 conditions.
Performance variables for both the bench
press and leg press revealed no differences
between the AAKG and placebo condition
for 1RM (Figure 2a), number of repetitions
performed (Figure 2b), or total volume of
work performed (Figure 2c).

7.56, p < 0.01) and placebo conditions (t33 =
8.45, p < 0.01) across time. Further, BLA
levels were also significantly greater post
leg-press in the AAKG (t33 = 9.23, p < 0.01)
and placebo (t33 = 8.10, p < 0.01) across
time.

Figure 3. Blood lactate values after muscular
endurance testing for the two conditions. Blood
lactate increased significantly across time in both
conditions (#p < 0.01), however there were no
differences between values after upper-body (UB) or
lower-body (LB) exercises.

DISCUSSION
The major findings of this study were that
acute ingestion of an AAKG supplement
had no effect on muscular strength,
endurance, or BLA concentration during
resistance exercise in ROTC Cadets. These
findings serve to support previous work by
Fricke (7) and Greer (8) that demonstrated
no ergogenic benefits with L-arginine
ingestion.
The lack of ergogenic benefits may indicate
that
chronic
use
of
L-arginine
supplementation may be necessary for
improved muscular performance. NO has
been shown to reduce contractile force in
mammalian skeletal muscle, thus a single
dose may be inadequate to achieve acute
changes in 1RM strength (13). Campbell et
al. (3) did observe increased 1RM bench

Figure 2. Results for (a) 1RM, (b) repetitions
performed, and (c) total load between the AAKG
and placebo conditions. No differences between the
two conditions were seen for any of the variables.

Repeated measures ANOVA for BLA
revealed no interaction or main effects for
condition; however, a significant main
effect for time was revealed (F2, 58 = 101.13,
p < 0.01). Blood lactate values (Figure 3)
did increase significantly from baseline to
post-bench press in both the AAKG (t33 =
International Journal of Exercise Science
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press strength in well-trained participants
after 8 weeks of AAKG supplementation
(12 g per day). Interestingly, improvements
in
strength
performance
weren’t
accompanied by muscle hypertrophy or
changes in body composition even though
participants lifted 4 days per week. An
investigation by Elam and colleagues (5)
reported increases in overall strength and
lean body mass after 5 weeks of L-arginine
and
ornithine
supplementation
(5).
Regrettably, this study used a posttest-only
design, so the groups’ initial strength and
lean muscle mass values may have differed.

AAKG may not be sufficient to facilitate an
ergogenic effect in normal healthy
individuals (10). Liu et al. (9) reported no
significant difference in plasma NO2 and
NO3
concentrations
after
orally
supplementing ten healthy male athletes
with 3000 mg of L-arginine or placebo for 3
days.
Finally,
the
difference
in
methodology between this study and prior
research does suggest that future studies
should focus on combining repeated bouts
of strength training exercises with a longer
(> 10 days) AAKG loading phase.
In
conclusion,
acute
AAKG
supplementation provided no ergogenic
benefit in this study. Future acute and
chronic studies on L-arginine are needed to
further
elucidate
the
underlying
mechanisms of action in conjunction with
measurements of resistance training
performance. This would provide a much
better understanding of the ergogenic
potential of supplements containing Larginine.

Similar to Greer and Jones (8), in this study
AAKG supplementation provided no
ergogenic benefit during upper or lower
body
muscular
endurance
testing.
Furthermore, the authors speculated that
AAKG supplementation may actually be
counterproductive to muscular endurance
performance by NO stimulated blood flow
to the exercising muscle, thereby limiting a
full range of motion for certain exercises.
Surprisingly, no differences were observed
in BLA concentration with AAKG
supplementation
during
muscular
endurance testing. If L-arginine leads to
vasodilatation of blood vessels via NO
production, one might assume BLA
concentration would have been reduced
with AAKG use. There is some recent
evidence to suggest acute L-arginine
supplementation doesn’t augment muscle
blood flow during resistance training as
much as first hypothesized (6, 12).

ACKNOWLEDGEMENTS
The authors wish to thank Justin Russell
and Dorothy Youmans for their valuable
assistance with this project.
REFERENCES
1. Alvares TS, Meirelles CM, Bhambhani YN,
Paschoalin VM, Gomes PS. L-Arginine as a potential
ergogenic aid in healthy subjects. Sports Med 41(3):
233-248, 2011.
2. Baechle TR, Earle RW. National Strength &
Conditioning Association (U.S.). Essentials of
strength training and conditioning. 3rd ed.,
Champaign, IL: Human Kinetics. xiv, p. 641, 2008.

There are also general limitations with this
study. First, L-arginine and NO production
were not measured in the blood stream,
thereby limiting our ability to measure oral
AAKG efficacy. Secondly, an acute dose of
International Journal of Exercise Science

3. Campbell B, Roberts M, Kerksick C, Wilborn C,
Marcello B, Taylor L, Nassar E, Leutholtz B, Bowden
R, Rasmussen C, Greenwood M, Kreider R.
Pharmacokinetics, safety, and effects on exercise

96

http://www.intjexersci.com

EFFECTS OF L-ARGININE ON RESISTANCE PERFORMANCE
performance of L-arginine alpha-ketoglutarate in
trained adult men. Nutrition 22(9): 872-881, 2006.

14. Stevens BR, Godfrey MD, Kaminski TW, Braith
RW. High-intensity dynamic human muscle
performance enhanced by a metabolic intervention.
Med Sci Sports Exerc 32(12): 2102-2108, 2000.

4. Campbell BI, La Bounty PM, Roberts M. The
ergogenic potential of arginine. J Int Soc Sports Nutr
1(2): 35-38, 2004.

15. Villaverde AB, Santos RS, Pacheco MTT, Martins
RABL, Giana HE, Baptista F, Zangaro RA. Study of
the effect of oral administration of L-arginine on
muscular performance in healthy volunteers: An
isokinetic study. Isokinet Exerc Sci 10(3): 153-158,
2002.

5. Elam RP, Hardin DH, Sutton RA, Hagen L. Effects
of arginine and ornithine on strength, lean body
mass and urinary hydroxyproline in adult males. J
Sports Med Phys Fitness 29(1): 52-56, 1989.
6. Fahs CA, Heffernan KS, Fernhall B.
Hemodynamic and vascular response to resistance
exercise with L-arginine. Med Sci Sports Exerc 41(4):
773-779, 2009.

16. Zajac A, Poprzecki S, Zebrowska A, Chalimoniuk
M,
Langfort
J.
Arginine
and
ornithine
supplementation increases growth hormone and
insulin-like growth factor-1 serum levels after
heavy-resistance
exercise
in
strength-trained
athletes. J Strength Cond Res 24(4): 1082-1090, 2010.

7. Fricke O, Baecker N, Heer M, Tutlewski B,
Schoenau E. The effect of L-arginine administration
on muscle force and power in postmenopausal
women. Clin Physiol Funct Imaging 28(5): 307-311,
2008.
8. Greer BK, Jones BT. Acute arginine
supplementation fails to improve muscle endurance
or affect blood pressure responses to resistance
training. J Strength Cond Res, 25(7): 1789-1794, 2011.
9. Liu TH, Wu CL, Chiang CW, Lo YW, Tseng HF,
Chang CK. No effect of short-term arginine
supplementation on nitric oxide production,
metabolism and performance in intermittent
exercise in athletes. J Nutr Biochem 20(6): 462-468,
2009.
10. Paddon-Jones D, Borsheim E, Wolfe RR.
Potential ergogenic effects of arginine and creatine
supplementation. J Nutr 134(10): 2888S-2894S, 2004.
11. Pollock ML, Wilmore JH. Exercise in health and
disease : evaluation and prescription for prevention
and rehabilitation. 2nd ed. Philadelphia: W.B.
Saunders. xiii, p. 741, 1990
12. Robinson TM, Sewell DA, Greenhaff PL. Larginine ingestion after rest and exercise: effects on
glucose disposal. Med Sci Sports Exerc 35(8): 13091315, 2003.
13. Stamler JS, Meissner G. Physiology of nitric oxide
in skeletal muscle. Physiol Rev 81(1): 209-237, 2001.

International Journal of Exercise Science

97

http://www.intjexersci.com

